Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · Real-Time Price · USD
4.290
+0.070 (1.66%)
At close: Mar 9, 2026, 4:00 PM EDT
4.210
-0.080 (-1.86%)
After-hours: Mar 9, 2026, 7:58 PM EDT
Aquestive Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 524 | 788 | 325 | 135 | 49 | 156 | |
| Market Cap Growth | 90.77% | 142.81% | 140.67% | 176.07% | -68.73% | -13.14% | |
| Enterprise Value | 445 | 700 | 284 | 155 | 85 | 169 | |
| Last Close Price | 4.29 | 6.46 | 3.56 | 2.02 | 0.90 | 3.89 | |
| PS Ratio | 11.75 | 17.69 | 5.64 | 2.67 | 1.02 | 3.07 | |
| PB Ratio | - | -23.41 | -5.40 | -1.27 | -0.41 | -1.90 | |
| EV/Sales Ratio | 9.99 | 15.73 | 4.93 | 3.06 | 1.79 | 3.32 | |
| Debt / Equity Ratio | -1.26 | -1.26 | -0.63 | -0.31 | -0.48 | -0.69 | |
| Net Debt / Equity Ratio | 2.34 | 2.34 | 0.56 | -0.09 | -0.25 | -0.35 | |
| Net Debt / EBITDA Ratio | 1.12 | 1.12 | 1.12 | -0.69 | -0.76 | -0.90 | |
| Net Debt / FCF Ratio | 1.49 | 1.49 | 0.93 | -1.28 | -2.79 | -0.84 | |
| Asset Turnover | 0.34 | 0.34 | 0.73 | 0.88 | 0.80 | 0.81 | |
| Inventory Turnover | 3.04 | 3.04 | 2.79 | 3.32 | 3.95 | 4.61 | |
| Quick Ratio | 2.92 | 2.92 | 4.18 | 1.77 | 0.81 | 1.83 | |
| Current Ratio | 3.14 | 3.14 | 4.68 | 2.24 | 1.01 | 2.15 | |
| Return on Assets (ROA) | -33.92% | -33.92% | -24.21% | -16.49% | -44.16% | -34.71% | |
| Return on Capital Employed (ROCE) | -63.00% | -63.00% | -37.30% | -38.60% | -239.80% | -86.60% | |
| Earnings Yield | -16.00% | -10.63% | -13.60% | -5.83% | -111.37% | -45.15% | |
| FCF Yield | -10.12% | -6.72% | -11.07% | -5.47% | -22.20% | -21.69% | |
| Buyback Yield / Dilution | -23.29% | -23.29% | -41.58% | -25.69% | -27.99% | -13.15% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.